Abstract:It has been revealed from microarray data analysis that long intergenic non-coding RNA 02454 (LINC02454) is highly expressed in papillary thyroid cancer (PTC). The aim of the present study was to explore the potential role of LINC02454 in the tumorigenesis of PTC. The mRNA expression levels of LINC02454 were assessed using data from The Cancer Genome Atlas (TCGA) and the GSE66783 cohort in thyroid cancer, and were validated using reverse transcription-quantitative PCR in 104 patients with PTC recruited in the present study. The association between the LINC02454 mRNA expression levels and the clinicopathological features of the 104 patients with PTC were also analyzed. Functional enrichment analyses were conducted on the differentially expressed genes in the high and low LINC02454 expression groups that were identified from the TCGA cohort. RNA interference, using short interfering (si)RNA against LINC02454, was used to investigate the role of LINC02454 in the biological functions of PTC cells in vitro. The expression level of LINC02454 was significantly increased in PTC tissues (P=0.0011) and was significantly associated with a larger tumor size, T stage, an advanced TNM stage and an increased lymph node metastasis (P<0.05), which was consistent with that in the TCGA and GSE66783 cohort. High expression levels of LINC02454 were observed in patients with PTC that also had BRAF mutations (P<0.001), and were significantly associated with a poorer disease-free survival in the TCGA cohort (P<0.05). Functional enrichment analysis indicated that LINC02454-related genes were significantly enriched in Gene Ontology terms, such as ‘positive regulation of cell proliferation’, ‘positive regulation of cell division’ and ‘cell adhesion’, and the following Kyoto Encyclopedia of Genes and Genomes pathways: ‘Pathways in cancer’ ‘proteoglycans in cancer’ and ‘ECM-receptor interaction’. In vitro, the knockdown of LINC02454 markedly arrested the cells in the G0/G1 phase of the cell cycle, and also led to an overall increase in apoptosis, as well as to an unexpected decrease in cell proliferation. LINC02454 may thus potentially function as an oncogene, which inhibits the apoptosis and enhances proliferation of PTC cells. Thus, as suggested by the findings of the present study, LINC02454 may be used as a diagnostic and prognostic biomarker for PTC in the future.

Long Noncoding RNA HIT000218960 Promotes Papillary Thyroid Cancer Oncogenesis and Tumor Progression by Upregulating the Expression of High Mobility Group AT-hook 2 (HMGA2) Gene

Identification of Specific Long Non-Coding RNA Expression: Profile and Analysis of Association with Clinicopathologic Characteristics and BRAF Mutation in Papillary Thyroid Cancer

Long Noncoding RNA Small Nucleolar RNA Host Gene 12 Promotes Papillary Thyroid Carcinoma Cell Growth and Invasion by Targeting Mir-16-5p.

Long Noncoding RNA RP11‐547D24.1 Regulates Proliferation and Migration in Papillary Thyroid Carcinoma: Identification and Validation of a Novel Long Noncoding RNA Through Integrated Analysis of TCGA Database

Long Noncoding RNA CNALPTC1 Promotes Cell Proliferation and Migration of Papillary Thyroid Cancer Via Sponging Mir-30 Family.

LncRNA ENST00000539653 Acts As an Oncogenic Factor Via MAPK Signalling in Papillary Thyroid Cancer

Identification of Long Noncoding RNAs Associated With the Clinicopathological Features of Papillary Thyroid Carcinoma Complicated With Hashimoto’s Thyroiditis

Overexpression of Novel Long Intergenic Non-Coding RNA LINC02454 is Associated with a Poor Prognosis in Papillary Thyroid Cancer

Mir-744–5P Mediates Lncrna HOTTIP to Regulate the Proliferation and Apoptosis of Papillary Thyroid Carcinoma Cells

Long Intergenic Non-Coding RNA 271 is Predictive of a Poorer Prognosis of Papillary Thyroid Cancer

Upregulation of LINC00887 Promotes Cell Proliferation, Growth and Invasion

Mitotically associated long non-coding RNA is a tumor promoter in anaplastic thyroid cancer

Tumor-Infiltrating Immune Cell Landscapes in the Lymph Node Metastasis of Papillary Thyroid Cancer

Expression of lncRNA-HOTAIR in the serum of patients with lymph node metastasis of papillary thyroid carcinoma and its impact.

Stimulation of TLR4 by LMW-HA Induces Metastasis in Human Papillary Thyroid Carcinoma through CXCR7

Long Non-Coding RNA TTN-AS1 Facilitates Tumorigenesis of Papillary Thyroid Cancer Through Modulating the Mir-153-3p/znrf2 Axis.

Genomic Amplification Of Long Noncoding Rna Hotairm1 Drives Anaplastic Thyroid Cancer Progression Via Repressing Mir-144 Biogenesis

Overexpression of LncRNA HOTAIR is Associated with Poor Prognosis in Thyroid Carcinoma: A Study Based on TCGA and GEO Data

Long non‐coding RNA AGAP2-AS1 promotes proliferation and metastasis in papillary thyroid cancer by miR-628-5p/KLF12 axis

Transcriptomic Signature Associated with Carcinogenesis and Aggressiveness of Papillary Thyroid Carcinoma

LncRNA GLTC targets LDHA for succinylation and enzymatic activity to promote progression and radioiodine resistance in papillary thyroid cancer